PRDM16 expression in the developing mouse embryo

Acta Histochemica

Volumn 113, Issue 2, 2011, Pages 150-155

  Horn, Kristin H ^a   Warner, Dennis R ^a   Pisano, Michele ^a   Greene, Robert M ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Development; Embryo; MEL1; PRDM16; Transcription factor

Indexed keywords

PR DOMAIN CONTAINING PROTEIN 16; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; MOUSE; MOUSE EMBRYO; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ANIMALS; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; FEMALE; MALE; MICE; MICE, INBRED ICR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

MURINAE;

EID: 79151482772     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2009.09.006     Document Type: Article

References (22)

1. Bjork B.C., Vieira A.R., Faust S., Camper S.A., Murray J.C., Beier D.R. Phenotypic, genetic, and developmental characterization of CPO1, a recessive ENU-induced mouse model of cleft palate 2006, Mouse Molecular Genetics Cold Spring Harbor Press, Woodbury, NY, p. 27.
2. Buyse I., Shao G., Huang S. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1 A protein. Proc Natl Acad Sci USA 1995, 92:4467-4471.
3. Fears S., Mathieu C., Zeleznik-Le N., Huang S., Rowley J.D., Nucifora G. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc Natl Acad Sci USA 1996, 93:1642-1647.
4. Kajimura S., Seale P., Tomaru T., Erdjument-Bromage H., Cooper M.P., Ruas J.L., et al. Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev 2008, 22:1397-1409.
5. Keller A.D., Maniatis T. Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev 1991, 5:868-879.
6. Kinameri E., Inoue T., Aruga J., Imayoshi I., Kageyama R., Shimogori T., et al. Prdm proto-oncogene transcription factor family expression and interaction with the Notch-Hes pathway in mouse neurogenesis. PLoS ONE 2008, 3:e3859.
7. Lahortiga I., Agirre X., Belloni E., Vazquez I., Larrayoz M.J., Gasparini P., et al. Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells. Oncogene 2004, 23:311-316.
8. Mochizuki N., Shimizu S., Nagasawa T., Tanaka H., Taniwaki M., Yokota J., et al. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 2000, 96:3209-3214.
9. Nishikata I., Sasaki H., Iga M., Tateno Y., Imayoshi S., Asou N., et al. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 2003, 102:3323-3332.
10. Nishikata I., Sasaki H., Iga M., Tateno Y., Imayoshi S., Asou N., et al. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 2003, 102:3323-3332.
11. Nucifora G., Laricchia-Robbio L., Senyuk V. EVI1 and hematopoietic disorders: history and perspectives. Gene 2006, 368:1-11.
12. Seale P., Bjork B.C., Yang W., Kajimura S., Chin S., Kuang S., et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008, 454:961-967.
13. Seale P., Kajimura S., Yang W., Chin S., Rohas L.M., Uldry M., et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab 2007, 6:38-54.
14. Shing D.C., Trubia M., Marchesi F., Radaelli E., Belloni E., Tapinassi C., et al. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice. J Clin Invest 2007, 117:3696-3707.
15. Sood R., Talwar-Trikha A., Chakrabarti S.R., Nucifora G. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1. Leukemia 1999, 13:348-357.
16. Trubia M., Albano F., Cavazzini F., Cambrin G.R., Quarta G., Fabbiano F., et al. Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia. Leukemia 2006, 20:48-54.
17. Tseng Y.H., Kokkotou E., Schulz T.J., Huang T.L., Winnay J.N., Taniguchi C.M., et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008, 454:1000-1004.
18. Van Campenhout C., Nichane M., Antoniou A., Pendeville H., Bronchain O.J., Marine J.C., et al. Evi1 is specifically expressed in the distal tubule and duct of the Xenopus pronephros and plays a role in its formation. Dev Biol 2006, 294:203-219.
19. Warner D.R., Horn K.H., Mudd L., Webb C.L., Greene R.M., Pisano M.M. PRDM16/MEL1: a novel Smad binding protein expressed in murine embryonic orofacial tissue. Biochim Biophys Acta 2007, 1773:814-820.
20. Wieser R. The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene 2007, 396:346-357.
21. Xiao Z., Zhang M., Liu X., Zhang Y., Yang L., Hao Y. MEL1S not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21). Leuk Res 2006, 30:332-334.
22. Yoshida M., Nosaka K., Yasunaga J., Nishikata I., Morishita K., Matsuoka M. Aberrant expression of the MEL1 S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 2004, 103:2753-2760.